Intralipid: fat emulsion for parenteral nutrition
Intralipid is a fat emulsion intended for parenteral nutrition, i.e. for introducing nutrients into the body through a vein. The drug is produced in Sweden by Pharmacia and is used in the treatment of various diseases.
Composition and release forms
Intralipid is a fat emulsion containing fractionated soybean oil, fractionated egg phospholipids, glycerin and water for injection. The drug is available in the form of an emulsion for fat infusions of 10% and 20%. Intralipid 30% is synonymous with the drug.
Indications for use
Intralipid is used for diseases of the digestive tract, unconsciousness, fasting in the preoperative period lasting more than 3 days, extensive burns, and severe infectious diseases.
Contraindications and side effects
Intralipid is contraindicated in case of shock in the initial stage and severe lipid metabolism disorders. When using the drug, side effects may occur, such as fever, chills, nausea and vomiting.
Interaction and overdose
There is no data on the interaction of Intralipid with other drugs. There is also no evidence of drug overdose.
special instructions
Intralipid should be used with caution in patients with renal failure, decompensated diabetes mellitus, pancreatitis, liver dysfunction, hypothyroidism, and sepsis. Careful monitoring of serum triglyceride levels is necessary. The drug should be used with caution in patients with an allergy to soy protein (only after allergy testing). When prescribing the drug to premature infants with hyperbilirubinemia and newborns, as well as when pulmonary hypertension is suspected, monitoring of platelet counts, liver tests and serum triglyceride concentrations is necessary.
conclusions
Intralipid is a fat emulsion used for parenteral nutrition. The drug is used for various diseases and requires caution when used in certain categories of patients. When using Intralipid, you must follow your doctor's recommendations and carefully monitor the patient's condition.